Luke Semrau
Overview
Explore the profile of Luke Semrau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
9
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Semrau L
J Med Philos
. 2024 Sep;
49(6):522-531.
PMID: 39222933
Simon Rippon, revising an earlier argument against kidney sales, now claims that offers involving the performance of invasive acts, when extended to people under pressure, constitute a kind of rights...
2.
Semrau L
J Med Ethics
. 2024 Jul;
PMID: 39019494
In a recent article, Albertsen both elaborates and levels a justice-based objection to kidney sales. In the present article, I show that Albertsen has crucially misunderstood the best option argument....
3.
Semrau L
J Med Philos
. 2024 Mar;
49(3):257-270.
PMID: 38530655
It is widely agreed that living kidney donation is permitted but living kidney sales are not. Call this the Received View. One way to support the Received View is to...
4.
Semrau L
Bioethics
. 2023 Aug;
37(9):831-837.
PMID: 37638703
I shall argue, first, that potential kidney donors may be subject to harmful pressure to donate. This pressure may take almost any form; people have diverse interests, and anything that...
5.
Semrau L, Matas A
Am J Transplant
. 2022 Jun;
22(11):2509-2514.
PMID: 35751488
The kidney shortage continues to be a crisis for our patients. Despite numerous attempts to increase living and deceased donation, annually in the United States, thousands of candidates are removed...
6.
Semrau L
J Med Ethics
. 2019 Sep;
46(4):277-278.
PMID: 31527143
Here, I briefly respond to a recent paper by Julian Koplin, in which he criticises my earlier work in this journal. I show that Koplin has misunderstood the distinction I...
7.
Semrau L
J Med Philos
. 2017 Nov;
42(6):634-652.
PMID: 29149334
Julian Koplin, drawing extensively on empirical data, has argued that vendors, even in well-regulated kidney markets, are likely to be significantly harmed. I contend that his reasoning to this conclusion...
8.
Semrau L
Bioethics
. 2016 Oct;
31(3):190-198.
PMID: 27767220
Erik Malmqvist defends the prohibition on kidney sales as a justifiable measure to protect individuals from harms they have not autonomously chosen. This appeal to 'group soft paternalism' requires that...
9.
Semrau L
J Med Ethics
. 2014 Sep;
41(6):443-6.
PMID: 25256300
Simon Rippon has recently argued against kidney markets on the grounds that introducing the option to vend will result in many people, especially the poor, being subject to harmful pressure...